Does bacitracin ointment prevent wound infection?

In a randomized controlled trial it prevented infection about as well as plain white petrolatum, with no significant advantage, and it caused allergic reactions that petrolatum did not.

Can bacitracin cause allergic reactions?

Yes. It is a recognized cause of allergic contact dermatitis, and rare but serious anaphylaxis has been reported after topical use and surgical wound irrigation.

What is triple antibiotic ointment?

It typically combines bacitracin with neomycin and polymyxin B to cover a broader range of skin bacteria.

What does bacitracin work against?

It is active mainly against Gram-positive bacteria by blocking bacterial cell-wall synthesis.

EMA-approved

Bacitracin — Complete Research Guide (2026)

Last updated 2026-06-30

TL;DR

Bacitracin is a peptide catalogued under Cyclic & Antimicrobial (Cyclic peptide antibiotic). It is described as: Cell wall synthesis (undecaprenyl-PP). Documented context: Topical antibiotic. Neutral reference entry; EU status: EU-approved prescription medicine.

What is Bacitracin?

Bacitracin is a cyclic peptide antibiotic (derived from Bacillus species) active mainly against Gram-positive bacteria. It is used almost exclusively topically - in ointments, frequently combined with neomycin and polymyxin B - because systemic administration causes serious nephrotoxicity; topical products are widely available over the counter.

The evidence for topical prophylaxis is modest: a randomized controlled trial found bacitracin ointment no more effective than plain white petrolatum for clean surgical wounds, and it is a recognized cause of allergic contact dermatitis and, rarely, anaphylaxis.

How does Bacitracin work?

Bacitracin inhibits bacterial cell-wall synthesis by binding undecaprenyl (C55-isoprenyl) pyrophosphate and blocking its dephosphorylation.

This interrupts the lipid-carrier cycle required to assemble peptidoglycan, halting cell-wall construction.

What does the research say about Bacitracin?

Bacitracin ointment is used to prevent infection in minor wounds, but in a randomized controlled trial of ambulatory-surgery patients its infection rate was not superior to plain white petrolatum. ^[1]
Because plain white petrolatum matched bacitracin's infection prevention in that trial without causing allergy, the evidence supports bland petrolatum as a reasonable alternative for clean wounds. ^[1]

Clinical research & studies

The references below are the primary sources cited throughout this guide. Each links directly to PubMed or the regulator. Where evidence is preclinical (animal or in-vitro), that is stated rather than implied.

[1] Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment. A randomized controlled trial — Smack DP et al., JAMA 1996. (Randomized controlled trial)
[2] Irritation and allergy patch test analysis of topical treatments commonly used in wound care: evaluation on normal and compromised skin — Trookman NS et al., Journal of the American Academy of Dermatology 2011. (Patch-test study)
[3] Anaphylaxis to topical bacitracin zinc ointment — Saryan JA et al., American Journal of Emergency Medicine 1998. (Case report)
[4] Intraoperative anaphylaxis to bacitracin during scleral buckle surgery — Caraballo J et al., Annals of Allergy, Asthma and Immunology 2017. (Case report)
[5] Intraoperative anaphylaxis to bacitracin during pacemaker change and laser lead extraction — Freiler JF et al., Annals of Allergy, Asthma and Immunology 2005. (Case report)
[6] Systemic Contact Dermatitis — Aquino M et al., Clinical Reviews in Allergy and Immunology 2019. (Review)

Dosing context

This is not medical advice or a usage recommendation. Dosing figures are reported research context only, cited from the published literature.

Marketed as a topical ointment applied thinly to minor cuts, scrapes, and burns, bacitracin is not intended for large wounds, prolonged use, or systemic administration.

This is context only and not a usage recommendation.

Side effects & safety profile

Bacitracin is a well-recognized topical contact allergen and can cause allergic contact dermatitis.

Rare but serious IgE-mediated anaphylaxis has been reported after topical application and after intraoperative wound irrigation.

Systemic (injectable) use is avoided because it causes nephrotoxicity, which is why bacitracin is confined to topical use.

Stacking & combinations

Bacitracin is commonly formulated with neomycin and polymyxin B as triple antibiotic ointment to broaden coverage across Gram-positive and Gram-negative skin organisms.

Finding Bacitracin vendors

This is an independent, neutral directory — we sell nothing and route no purchases. Use it to read regulatory context and (where available) genuine, moderated vendor information for your country.

Choose your country

We never list placeholder vendors. Pick your country to see neutral regulatory context.

Browse the directory

User reviews

No reviews yet

Reviews appear here once submitted and moderated. An aggregate rating is shown only after at least 5 genuine reviews — we never fabricate ratings.

Frequently asked questions

No - it is used almost exclusively topically. Systemic (injected) bacitracin causes serious kidney toxicity, so modern use is limited to skin and eye preparations.

References

[1] Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment. A randomized controlled trial — Smack DP et al., JAMA 1996. PMID: 8805732. View sourceStudy: Randomized controlled trialBacitracin ointment and plain white petrolatum had similar wound-infection rates, but only bacitracin caused allergic contact dermatitis.
[2] Irritation and allergy patch test analysis of topical treatments commonly used in wound care: evaluation on normal and compromised skin — Trookman NS et al., Journal of the American Academy of Dermatology 2011. PMID: 21247661. View sourceStudy: Patch-test studyAssessed irritation and allergy potential of common wound-care topicals, including bacitracin-containing products, on normal and compromised skin.
[3] Anaphylaxis to topical bacitracin zinc ointment — Saryan JA et al., American Journal of Emergency Medicine 1998. PMID: 9725969. View sourceStudy: Case reportDocumented anaphylaxis following application of topical bacitracin zinc ointment.
[4] Intraoperative anaphylaxis to bacitracin during scleral buckle surgery — Caraballo J et al., Annals of Allergy, Asthma and Immunology 2017. PMID: 29042173. View sourceStudy: Case reportReported intraoperative anaphylaxis attributed to bacitracin exposure during scleral buckle surgery.
[5] Intraoperative anaphylaxis to bacitracin during pacemaker change and laser lead extraction — Freiler JF et al., Annals of Allergy, Asthma and Immunology 2005. PMID: 16279570. View sourceStudy: Case reportDescribed intraoperative anaphylaxis to bacitracin during a pacemaker and lead procedure.
[6] Systemic Contact Dermatitis — Aquino M et al., Clinical Reviews in Allergy and Immunology 2019. PMID: 29766368. View sourceStudy: ReviewReviewed systemic contact dermatitis and identified topical allergens including bacitracin.

This article is for educational and research purposes only. Peptides discussed here are not approved for human consumption by the FDA, EMA, or equivalent regulators outside of specific clinical contexts. Always consult a licensed medical professional before any therapeutic use.